Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria

A marker of vascular dysfunction and progressive vascular disease

Ann Marie Schmidt, Jill P. Crandall, Osamu Hori, Rong Cao, Edward Lakatta

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Advanced glycation endproducts (AGEs), which accumulate in diabetic vasculature, result in enhanced expression of endothelial cell-associated vascular cell adhesion molecule-1 (VCAM-1) as well release of a soluble form of VCAM-1 (sVCAM-1) into culture supernatants. We hypothesized that sVCAM-1 in diabetic plasma might reflect early vascular perturbation in diabetic vasculopathy. Diabetic patients with microalbuminuria, a group with a high incidence of vascular complications, had increased plasma levels of sVCAM-1, ~1.5-fold greater than diabetic patients without microalbuminuria; P < 0.05. sVCAM-1 may be an indicator of ongoing cellular dysfunction in diabetes, as well as a dynamic surrogate marker for the effectiveness of therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)747-750
Number of pages4
JournalBritish Journal of Haematology
Volume92
Issue number3
StatePublished - 1996
Externally publishedYes

Fingerprint

Vascular Cell Adhesion Molecule-1
Vascular Diseases
Blood Vessels
Endothelial Cells
Biomarkers
Incidence

Keywords

  • Adhesion molecule
  • Diabetes
  • Glycation
  • Microalbuminuria
  • Vasculopathy

ASJC Scopus subject areas

  • Hematology

Cite this

Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria : A marker of vascular dysfunction and progressive vascular disease. / Schmidt, Ann Marie; Crandall, Jill P.; Hori, Osamu; Cao, Rong; Lakatta, Edward.

In: British Journal of Haematology, Vol. 92, No. 3, 1996, p. 747-750.

Research output: Contribution to journalArticle

@article{57019340f1b24b17b859d73605b34c81,
title = "Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease",
abstract = "Advanced glycation endproducts (AGEs), which accumulate in diabetic vasculature, result in enhanced expression of endothelial cell-associated vascular cell adhesion molecule-1 (VCAM-1) as well release of a soluble form of VCAM-1 (sVCAM-1) into culture supernatants. We hypothesized that sVCAM-1 in diabetic plasma might reflect early vascular perturbation in diabetic vasculopathy. Diabetic patients with microalbuminuria, a group with a high incidence of vascular complications, had increased plasma levels of sVCAM-1, ~1.5-fold greater than diabetic patients without microalbuminuria; P < 0.05. sVCAM-1 may be an indicator of ongoing cellular dysfunction in diabetes, as well as a dynamic surrogate marker for the effectiveness of therapeutic interventions.",
keywords = "Adhesion molecule, Diabetes, Glycation, Microalbuminuria, Vasculopathy",
author = "Schmidt, {Ann Marie} and Crandall, {Jill P.} and Osamu Hori and Rong Cao and Edward Lakatta",
year = "1996",
language = "English (US)",
volume = "92",
pages = "747--750",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria

T2 - A marker of vascular dysfunction and progressive vascular disease

AU - Schmidt, Ann Marie

AU - Crandall, Jill P.

AU - Hori, Osamu

AU - Cao, Rong

AU - Lakatta, Edward

PY - 1996

Y1 - 1996

N2 - Advanced glycation endproducts (AGEs), which accumulate in diabetic vasculature, result in enhanced expression of endothelial cell-associated vascular cell adhesion molecule-1 (VCAM-1) as well release of a soluble form of VCAM-1 (sVCAM-1) into culture supernatants. We hypothesized that sVCAM-1 in diabetic plasma might reflect early vascular perturbation in diabetic vasculopathy. Diabetic patients with microalbuminuria, a group with a high incidence of vascular complications, had increased plasma levels of sVCAM-1, ~1.5-fold greater than diabetic patients without microalbuminuria; P < 0.05. sVCAM-1 may be an indicator of ongoing cellular dysfunction in diabetes, as well as a dynamic surrogate marker for the effectiveness of therapeutic interventions.

AB - Advanced glycation endproducts (AGEs), which accumulate in diabetic vasculature, result in enhanced expression of endothelial cell-associated vascular cell adhesion molecule-1 (VCAM-1) as well release of a soluble form of VCAM-1 (sVCAM-1) into culture supernatants. We hypothesized that sVCAM-1 in diabetic plasma might reflect early vascular perturbation in diabetic vasculopathy. Diabetic patients with microalbuminuria, a group with a high incidence of vascular complications, had increased plasma levels of sVCAM-1, ~1.5-fold greater than diabetic patients without microalbuminuria; P < 0.05. sVCAM-1 may be an indicator of ongoing cellular dysfunction in diabetes, as well as a dynamic surrogate marker for the effectiveness of therapeutic interventions.

KW - Adhesion molecule

KW - Diabetes

KW - Glycation

KW - Microalbuminuria

KW - Vasculopathy

UR - http://www.scopus.com/inward/record.url?scp=0029960353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029960353&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 747

EP - 750

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -